NMTRQ — 9 Meters Biopharma Share News
0.000.00%
FinancialsHighly SpeculativeMicro Cap
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle
Brief: 9 Meters Biopharma Inc And Units Files For Bankruptcy Protection
9 Meters Biopharma slumps after filing for bankruptcy protection
Drug developer 9 Meters Biopharma files for bankruptcy protection (updated)
Drug developer 9 Meters Biopharma files for bankruptcy protection
U.S. STOCKS ON THE MOVE-Pinterest, Sunrun, Tencent Music
Brief: 9 Meters Biopharma Gets Notice Of Delisting Or Failure From Nasdaq
9 Meters Biopharma falls on delay of late-stage trial, CEO resignation
Brief: 9 Meters Biopharma Inc - Co Submitted Plan Of Compliance To Nasdaq To Regain Compliance With Stockholders' Equity Requirement
9 Meters Biopharma Inc reports results for the quarter ended in March - Earnings Summary
9 Meters Biopharma Inc expected to post a loss of 78 cents a share - Earnings Preview
Brief: 9 Meters Biopharma Enters Into Forbearance Agreement With Institutional Investor
U.S. STOCKS ON THE MOVE-Allete, Gilead Sciences, Arcutis
9 Meters Biopharma rises on positive FDA meeting for obesity drug
Brief: 9 Meters Biopharma Announces Successful Pre-Ind Meeting With FDA Regarding Its Gip Antagonist Nm-136 For Obesity